GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

The biobanking market is poised to expand as researchers continue to migrate toward the use of human tissues and biomaterials for primary research, and pharmaceutical and diagnostic-tool development. Facilities range from individual research laboratories to hospitals, academic centers and commercial entities, all involved in the collection of human tissues and biomaterials.

During this week’s podcast, biobanking expert Dr. Jim Vaught discusses how and why the biobanking and biospecimen research field has grown so rapidly. Based on his experience at the NCI, he talks about what has led to the development of biobanking best practices at NIH and ISBER and elsewhere. He answers questions such as how do researchers locate samples for their research and if there is a central database or web links that investigators can use. Dr. Vaught also describes what the world of biobanking will look like in the future.

Dr. Jim Vaught is the Deputy Director of the Office of Biorepositories and Biospecimen Research (OBBR). Dr. Vaught has been working in the field of biorepository and biospecimen science for more than 15 years. In 1999 he was one of the founding members of the International Society for Biological and Environmental Repositories (ISBER), and was its second president. Dr. Vaught is the new incoming editor-in-chief of Biopreservation and Biobanking, a journal published by Mary Ann Liebert, Inc.

Add a comment

Add a comment

Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

Be sure to take the GEN Poll

Climate Change

How would you describe the researchers response to the 2°C global temperature target?

They are right on the mark. A 2°C global temperature rise will push us further over the edge. We have to set a lower target.

A 2°C global temperature rise is a reasonable target on which to focus in order to diminish the impact of climate change.

We have already gone beyond the threshold for getting a handle on climate change. So now we just need to learn how to adapt to the inexorable climatic changes with which we will have to deal going forward.

They are right on the mark. A 2°C global temperature rise will push us further over the edge. We have to set a lower target.

38.9%

A 2°C global temperature rise is a reasonable target on which to focus in order to diminish the impact of climate change.

22.2%

We have already gone beyond the threshold for getting a handle on climate change. So now we just need to learn how to adapt to the inexorable climatic changes with which we will have to deal going forward.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.